Fox Run Management’s CareDx CDNA Stock Holding History

Fox Run Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,088	Closed	-$284K	–	903
2024 Q3	$284K	Sell	9,088 -16,850	-65%	-$419K	0.06%	568
2024 Q2	$403K	Buy	25,938 +12,416	+92%	+$150K	0.08%	482
2024 Q1	$143K	Buy	+13,522	New	+$135K	0.03%	676
2022 Q4	–	Sell	-10,869	Closed	-$185K	–	645
2022 Q3	$185K	Buy	+10,869	New	+$233K	0.07%	493
2018 Q3	–	Sell	-14,580	Closed	-$178K	–	598
2018 Q2	$178K	Buy	+14,580	New	+$167K	0.06%	589

Other funds holding CDNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fox Run Management's CDNA Position: Q4 2024 in Review

Fox Run Management sold out of CareDx (CDNA) in Q4 2024, closing a stake of 9,088 shares — an estimated $284K sold.

Fox Run Management first reported a position in CDNA in Q2 2018 and held it in 5 quarters. The position peaked at $403K in Q2 2024. 210 funds tracked by Wall St. Rank hold CDNA as of Q4 2024.

Fox Run Management reported no remaining CareDx position as of Q4 2024 after selling out during the quarter.
Fox Run Management sold 9,088 CareDx shares in Q4 2024, an estimated $284K.
Fox Run Management first reported a position in CareDx in Q2 2018 and held it in 5 quarters.
Fox Run Management's CareDx position peaked at $403K in Q2 2024.
210 funds tracked by Wall St. Rank held CareDx as of Q4 2024.

Based on Fox Run Management's 13F filing for Q4 2024, filed 11 Feb 2025.